Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglaite plus radiotherapy-based comprehensive treatment for lung cancer
ChiCTR2400087432Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial of kanglaite in bronchial carcinoma (2 arms), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Progression-free survival and Objective response rate. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
kanglaite
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2400087432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087432.